ArticleScientific reports2026
Association of body mass index and cardiovascular risk profile with ménière's disease: A case-control study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.The Laryngoscope · 2026Article
- Comorbidities and impact on quality of life in patients with Ménière's disease: a single-center cross-sectional study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case-control study investigated the association between Body Mass Index (BMI), cardiovascular risk factors, and Meniere’s disease (MD). We enrolled 100 patients with definite MD and 100 age- and sex-matched controls. We assessed BMI categories, cardiovascular risk factors, and medication use. Hearing loss was evaluated via pure-tone audiometry. Multivariable logistic regression, adjusted for confounders, identified independent associations. BMI distribution differed significantly. Overweight was more prevalent in MD patients (73% vs. 22%), while normal weight was less common (19% vs. 72%; p < 0.001). After adjustment, overweight remained independently associated with MD (aOR = 3.85, 95% CI: 1.92–7.72, p < 0.001). Warfarin showed a protective association (aOR = 0.32, 95% CI: 0.11–0.94, p = 0.04). Associations for diabetes and dyslipidemia lost significance after adjustment. Overweight is a strong, independent risk factor for MD. The protective association of warfarin suggests potential microvascular mechanisms, highlighting the importance of weight management in MD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.